JP2004519452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004519452A5 JP2004519452A5 JP2002554133A JP2002554133A JP2004519452A5 JP 2004519452 A5 JP2004519452 A5 JP 2004519452A5 JP 2002554133 A JP2002554133 A JP 2002554133A JP 2002554133 A JP2002554133 A JP 2002554133A JP 2004519452 A5 JP2004519452 A5 JP 2004519452A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- use according
- antigen
- compound
- polycationic compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 239000013543 active substance Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 238000007918 intramuscular administration Methods 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims 1
- 229930010555 Inosine Natural products 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 229960003786 inosine Drugs 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2001/000087 WO2001054720A1 (en) | 2000-01-28 | 2001-01-05 | Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| AT6722001 | 2001-04-25 | ||
| PCT/EP2002/000062 WO2002053184A2 (en) | 2001-01-05 | 2002-01-07 | Uses for polycationic compounds as vaccine adjuvants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004519452A JP2004519452A (ja) | 2004-07-02 |
| JP2004519452A5 true JP2004519452A5 (https=) | 2005-12-22 |
Family
ID=25608382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002554133A Pending JP2004519452A (ja) | 2001-01-05 | 2002-01-07 | ポリカチオン性化合物の用途 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2004519452A (https=) |
| CA (1) | CA2433794A1 (https=) |
| WO (1) | WO2002053184A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244438B2 (en) | 2001-01-05 | 2007-07-17 | Intercell Ag | Uses for polycationic compounds |
| EP1608402B1 (en) * | 2003-03-24 | 2010-10-20 | Intercell AG | Improved vaccines |
| WO2011101465A1 (en) | 2010-02-19 | 2011-08-25 | Intercell Ag | Ic31 nanoparticles |
| KR101586200B1 (ko) * | 2014-12-31 | 2016-01-18 | 성균관대학교산학협력단 | 면역자극 조성물, 이의 제조 방법, 및 이를 포함하는 면역요법 조성물 |
| JP7821486B2 (ja) * | 2019-09-19 | 2026-02-27 | アーエムヴェー ゲゼルシャフト ミット ベシュレンクテル ハフツング | 制御された活性物質放出のための押出型デポ剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB744988A (en) * | 1952-01-31 | 1956-02-15 | Allen & Hanburys Ltd | Improvements in preparations of insulin |
| GB8921470D0 (en) * | 1989-09-22 | 1989-11-08 | Peptide Technology Ltd | Vaccines |
| RS50101B (sr) * | 1996-02-24 | 2009-01-22 | Boehringer Ingelheim International Gmbh., | Farmaceutski preparati za imunomodulaciju |
| ATE241965T1 (de) * | 1999-01-13 | 2003-06-15 | Univ Johns Hopkins Med | Genetische immunisierung mit gleichzeitiger verabreichung von nukleinsäuren und zytokinen |
| PT1187629E (pt) * | 1999-04-19 | 2005-02-28 | Glaxosmithkline Biolog Sa | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador |
| AT408721B (de) * | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| RU2413520C2 (ru) * | 2000-06-08 | 2011-03-10 | Интерселл Аг | Вакцинная композиция, содержащая иммуностимулирующие олигодезоксинуклеотиды |
| AT410635B (de) * | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
-
2002
- 2002-01-07 WO PCT/EP2002/000062 patent/WO2002053184A2/en not_active Ceased
- 2002-01-07 CA CA002433794A patent/CA2433794A1/en not_active Abandoned
- 2002-01-07 JP JP2002554133A patent/JP2004519452A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003526662A5 (https=) | ||
| García et al. | An overview of adjuvant formulations and delivery systems | |
| WO2000062800A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| MX353044B (es) | Liberacion sostenida de anti-infecciosos. | |
| CY1110140T1 (el) | Εμβολιασμος με μηνιγγοκοκκικο συζευγμα | |
| JP2003528155A5 (https=) | ||
| JP2005519985A5 (https=) | ||
| JP2003506416A5 (https=) | ||
| EP2272531A3 (en) | Integration of meningococcal conjugate vaccination | |
| JP2003513935A5 (https=) | ||
| JP2006506441A5 (https=) | ||
| JP2002542204A5 (https=) | ||
| JP2002531521A5 (https=) | ||
| JP2002534481A5 (https=) | ||
| BR0010711A (pt) | Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes | |
| WO2002032378A3 (en) | Fusion cells and cytokine compositions for treatment of disease | |
| JP2004519452A5 (https=) | ||
| WO2001095934A3 (en) | The use of plant oil-bodies in vaccine delivery systems | |
| WO2000062802A3 (en) | Vaccine comprising rsv antigen and cpg oligonucleotide | |
| JP2004519453A5 (https=) | ||
| EP1905449A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
| RU2009142690A (ru) | Режим вакцинации для в-клеточной вакцины | |
| WO2002030458A8 (en) | Yersinia adhesion protein as vaccine adjuvant | |
| CA2364606A1 (en) | Oil-in-water emulsion for the use as medicament or for producing a medicament | |
| ATE334658T1 (de) | Arzneimittel zur verabreichung an schleimhäute |